openPR Logo
Press release

Pneumonia Vaccine Market to Witness Robust Expansion throughout the Forecast 2019-2026 | Panacea Biotec Limited, Pfizer Inc

10-18-2020 04:10 PM CET | Health & Medicine

Press release from: Allied Market Research

Pneumonia Vaccine Market

Pneumonia Vaccine Market

UPDATE AVAILABLE ON-DEMAND

According to the report by Allied Market Research, the global pneumonia vaccine market is estimated to register a CAGR of 5% from 2018 to 2025. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/2730

Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs, which results in filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at greatest risk of serious pneumococcal infections and even death.

Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that causes infection in the lungs.

The key factors that drive the growth of the global pneumonia vaccine market include increase in prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with development of such vaccines restrain the market growth. Development of protein-based combination pneumococcal vaccines is expected to offer lucrative opportunities for the expansion of this market during the forecast period.

Based on type, pneumococcal conjugate vaccine (PCV) is expected to maintain its dominant (more than half of the market share in 2017) position during the analysis period as it is been widely prescribed as compared to pneumococcal polysaccharide vaccine (PPV).

Based on product, the Prevnar 13 segment held the major market share in 2017 and is expected to dominate the market throughout the forecast period, owing to the wide usage and its efficiency in pneumonia prevention.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2730

Based on distribution channel, the distribution partner companies segment held majority of the market share in 2017, owing to the wide coverage of the private entities. This segment is expected to dominate the market during the forecast period due to majority of private vaccines purchases which are comparatively expensive are distributed from these companies. Hence, the distribution partner companies hold larger share.

Based on sector, the private sector dominates the overall market for pneumonia vaccines and is expected to dominate the market throughout the forecast period due to the higher prices of the vaccine in the private market.

North America accounted for nearly three-fifth of the global market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the higher prevalence in the developing countries such as India and China, increase in government healthcare expenditure, rise in demand for better healthcare, and surge in number of childbirths in the region. Moreover, government support and development of protein-based combination pneumococcal vaccines are the factors expected to present new growth opportunities to the players in this market

The Major Key Players Are:

Glaxosmithkline plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited), SK Bioscience, and Walvax Biotechnology Co., Ltd.

Access Full Report @ https://www.alliedmarketresearch.com/pneumonia-vaccine-market

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumonia Vaccine Market to Witness Robust Expansion throughout the Forecast 2019-2026 | Panacea Biotec Limited, Pfizer Inc here

News-ID: 2162976 • Views: 246

More Releases from Allied Market Research

Orthopedic Prosthetics Market Will Expand in the Coming Decade
Orthopedic Prosthetics Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Orthopedic Prosthetics market recent progressions. The Orthopedic Prosthetics market report is prepared after fundamental levels of research regarding the Orthopedic Prosthetics Industry. Orthopedic Prosthetics Market by Product (Upper Extremity Prosthetics, Lower Extremity Prosthetics, Liners, Sockets, and Modular Components) Technology (Conventional, Electric Powered, and Hybrid
Orthopedic Operating Tables Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Operating Tables Market by Technology (Non-powered Operating Tables and Powered Operating Tables) and End Users (Hospitals and Ambulatory Surgical Centers (ASCs)) – Global Opportunity and Forecast, 2019-2026”. The Global market size of Orthopedic Operating Tables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with
Orthopedic Consumables Market Analysis of The Current and Emerging Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Consumables Market by Product (Surgical Orthopedic Consumables, Wound-Management Orthopedic Consumables, and Others) and End Users (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), and Others) – Global Opportunity and Forecast, 2019-2026 The Global market size of Orthopedic Consumables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027
Intraosseous Infusion Device Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, “Intraosseous Infusion Device Market by Product Type (FAST1 device, Dieckmann Modified Needle, BIG device, EZ-IO device, Jamshidi Needle, FASTx device, and NIO), by Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), by Route of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head of Humerus), by End User (Hospitals, Emergency Medical Services, Ambulatory Surgical

All 5 Releases


More Releases for Pneumonia

Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth. Pneumonia is an
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,
Hospital-acquired Pneumonia Drugs Market: to reach over by 2020
Hospital-acquired Pneumonia Drugs Market: Overview Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat. Pneumonia is one of the prominent infections caused in hospital premises. Cases of
Global Pneumonia Market: Industry Analysis, outlook and Forecast by 2025
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Pneumonia Market Report 2018” which provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering U.S, and Europe along with the global market. The report profiles key players of the market including Merck & Co. Inc., Allergan
Pneumonia Diagnostics Market worth US$ 685 Mn by 2027
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report